OÜ Chemestmed

Active Registry code 12140551 OÜ Tartu linn Registered 29 Jul 2011

OÜ Chemestmed is a OÜ based in Tartu linn, registry code 12140551, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with 7 employees.

Turnover

0 €

State taxes

4 480 €

↓ 1.5% vs Q2 2026

Labour taxes

50 373 €

↑ 8.4% vs Q2 2026

Employees

−1 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

Labour taxes per employee 7 196 €

above 90% of companies

industry median 2 218 € · companies in the industry: 234
Revenue · 2025 0 €

above 5% of companies

industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q3 2026: 7 196 € · +23.9% vs Q2 2026 · industry median 2 218 € · above 90% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 7 · −12.5% vs Q2 2026

State taxes, € Q3 2026: 4 480 € · −1.5% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	—	4 480	50 373	7
Q2 2026	—	4 547	46 467	8
Q1 2026	—	—	43 162	8
Q4 2025	—	—	40 487	7
Q3 2025	—	25 316	34 627	7
Q2 2025	—	16 067	18 874	6
Q1 2025	—	—	5 043	2
Q4 2024	1 846	—	4 931	1
Q3 2024	1 904	—	5 579	1
Q2 2024	1 632	—	2 597	1
Q1 2024	—	—	936	1
Q4 2023	—	—	—	1
Q3 2023	—	—	—	—
Q2 2023	—	—	—	—
Q1 2023	—	—	—	—
Q4 2022	—	—	—	—
Q3 2022	—	—	—	—
Q2 2022	—	—	—	—
Q1 2022	—	—	—	—

Labour taxes per employee per month

2 399 €

Turnover per employee in the quarter

0 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025

Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: -1 649 153 € · −164 915 400.0% vs 2024 · industry median 0 € · above 2% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 2 956 256 € · +9.4% vs 2024

Equity, € thousand 2025: -1 646 652 € · −65 939.7% vs 2024

Employees 2025: 5 · +400.0% vs 2024 · industry median 1 · above 75% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	0	-1 649 153	305 808	2 956 256	-1 646 652	5
2024	0	1	41 288	2 701 201	2 501	1
2023	0	0	2 209	2 056 051	2 500	0
2022	0	0	—	1 613 679	2 500	0
2021	0	-1	—	1 326 703	2 500	0
2020	0	-2 340	—	933 277	2 501	0
2019	0	-844	—	763 006	4 841	0
2018	—	—	—	—	—	0
2017	—	—	—	—	—	0
2016	—	—	—	—	—	0
2015	—	—	—	—	—	0
2014	—	—	—	—	—	0
2013	—	—	—	—	—	0
2012	—	—	—	—	—	0
2011	—	—	—	—	—	0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on assets (ROA)

-55.8 %

Net profit / assets

Equity ratio

-55.7 %

Equity / assets

Debt ratio

155.7 %

Liabilities / assets

Current ratio

4.93

Current assets / current liabilities

Labour cost per employee per month

5 097 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	30 Jun 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	4 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	17 Jun 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	20 Jun 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	16 Jun 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	16 Jun 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	17 Jun 2020	Company’s own	e-Äriregister

Board

Mihkel Märtson
Board member · since 26 Jun 2023
Neinar Seli
Board member · since 26 Jun 2023

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Mihkel Märtson
Natural person · 2 500 €

100%

Beneficial owners

Mihkel Märtson
Direct ownership · since 29 Jun 2023

Founders and other persons

aktsiaselts RONDAM
Founder · 2 500 € · 28 Jul 2011

shared board members, owners or beneficial owners

Activities (EMTAK)

72101Research and experimental development on natural sciences and engineering Main

Rulings 11

All rulings (PDF)

Rulings
Number, date	Title	State	Document
Ä 20056946 / 11 2 Sep 2023	Amendment entry	In force 2 Sep 2023	PDF
Ä 20056946 / 10 26 Jun 2023	Amendment entry	In force 26 Jun 2023	PDF
Ä 20056946 / 9 13 Jul 2022	Amendment under Commercial Code § 525 (2)	In force 13 Jul 2022	PDF
Ä 20056946 / 8 11 Jul 2022	Amendment entry	In force 11 Jul 2022	PDF
Ä 20056946 / 7 7 Mar 2022	Amendment entry	In force 7 Mar 2022	PDF
Ä 20056946 / 6 10 Oct 2018	Amendment under Commercial Code § 525 (2)	In force 10 Oct 2018	PDF
Ä 20056946 / 5 17 Jan 2018	Amendment entry	In force 17 Jan 2018	PDF
Ä 20056946 / 4 22 Dec 2017	Amendment entry	In force 22 Dec 2017	PDF
Ä 20056946 / 3 2 Dec 2017	Amendment entry	In force 2 Dec 2017	PDF
Ä 20056946 / 2 1 Aug 2011	Entry made by the register on its own initiative	In force 1 Aug 2011	PDF
Ä 20056946 29 Jul 2011	First entry	In force 29 Jul 2011	PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data

OÜ Chemestmed

Position in the industry Scientific research and development · EMTAK 72

Taxes and turnover

Financials by year

Financial ratios for 2025

Annual reports

Board

Right of representation

Owners

Beneficial owners

Founders and other persons

Related companies

Activities (EMTAK)

Rulings 11